ICUI vs MRK
ICU Medical, Inc. vs Merck & Co. — AI-powered side-by-side comparison
ICUI
ICU Medical, Inc.
48
Watch
VS
| Metric | ICUI | MRK |
|---|
| AI Score |
48
|
70
|
| Price |
$181.87
|
$130.34
|
| P/E Ratio |
151.73×
|
103.53×
|
| ROE |
0.0%
|
34.7%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
37.6%
|
75.4%
|
| Debt / Equity |
0.60×
|
1.29×
|
| Dividend Yield |
0.0%
|
2.6%
|
| RSI (14) |
72.5
|
64.5
|
| Beta |
0.754
|
0.207
|
| Expected Upside |
—
|
—
|
AI Committee View
Current Innellis committee reasoning for ICUI versus MRK.
MRK leads by 22 points.
MRK scores 70/100 (Buy) versus ICUI at 48/100 (Watch).
ICUI Committee View
50% agreement
6 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Growth Analyst remains cautious — revenue declining -10.9% yoy -- this is not a growth story right now. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- P/E of 99.6 is expensive by classic value standards — Value
- ROE of only 2.2% -- cheap may mean cheap for a reason — Value
- Revenue declining -10.9% YoY -- this is not a growth story right now — Growth
MRK Committee View
75% agreement
4 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical